from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3443c/rplM

LFCtreatmentdescriptionclass of inhibitor

1.441

Amikacinug/mL Amikacintranslation

1.862

Cap5-10ug/mL Capreomycintranslation

1.786

Rox10-50 ug/mL Roxithromycintranslation

1.373

SM2-5 ug/mL Streptomycintranslation

1.354

Tet5-10 ug/mL Tetracyclinetranslation

-1.329

Rif0.2-5ug/mL Rifampicintranscription

-0.251

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.125

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.221

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.749

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.489

Clofazimine10-13 ug/mL Clofaziminerespiration

0.147

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.165

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.774

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.055

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.008

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.156

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.275

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.932

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.127

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.877

KCN5-20 ug/mL Potassium cyaniderespiration

-0.455

NaN30.2-2 mM Sodium aziderespiration

0.809

Nigericin50 uM Nigericinrespiration

-1.523

TRC10-150 ug/mL Triclosanrespiration

-1.096

TRZ10-25 ug/mL Thioridazinerespiration

1.385

Valinomycin0.5-10 uM Valinomycinrespiration

0.693

ZnSO42 mM ZnSO4respiration

0.370

menadione6-10 ug/mL Menadionerespiration

0.085

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.622

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.361

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.727

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.090

NRP_1Non-replicating persistence stage 1dosRassociated

0.617

Amp0.2mg/mL AmpicillincellWall

0.295

Cephalexin20-100 ug/mL CephalexincellWall

0.879

Cerulenin0.32-5 ug/mL CerulenincellWall

0.288

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.240

EMB10-20 ug/mL EthambutolcellWall

0.444

Eta12-40 ug/mL EthionamidecellWall

0.804

INH0.2-0.4 ug/mL IsoniazidcellWall

0.462

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.022

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.496

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.205

BZA0.12 mg/mL BenzamidearomaticAmides

-0.039

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.067

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.027

H2O24 mM hydrogen peroxideDNAdamaging

1.100

Levo10 ug/mL LevofloxacinDNAdamaging

0.683

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.557

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.899

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.777

UVUV-irradiationDNAdamaging

-1.153

ARP41-4 ug/mL Antitubercular compound ARP4?

0.456

Antimycin12.5-50 ug/mL Antimycin A?

0.525

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.160

PA_110-50 ug/mL Antitubercular compound PA-1?

0.162

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.756

PA8240.2-2 ug/mL PA-824?

-1.019

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.089

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.267

Verapamil50 uM Verapamil?

0.283

mercaptoethanol2 mM 2-Mercaptoethanol?

0.555

methoxatin10-20 ug/mL Methoxatin?